Jian Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jianzhong Chen
School of Science, Shandong Jiaotong University, Jinan, 250357, China
11 shared publications - Wanchun Yang
School of Science, Shandong Jiaotong University, Jinan 250357, China
7 shared publications - Lu Zhao
School of Science, Shandong Jiaotong University, Jinan 250357, China
6 shared publications - Benzheng Wei
Center for Medical Artificial Intelligence, Qingdao Academy of Chinese Medical Sciences, Shandong University of traditional Chinese Medicine, Qingdao, China
4 shared publications Lu Zhao
School of Science
4 shared publications- Guodong Hu
Shandong Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou 253023, China
3 shared publications
Latest Publications
- Open Access
Recent Progress and Prospect in Studying Selective Inhibitors Toward Bromodomain Family Members
Bromodomain (BRD)-containing proteins are gaining attention as key targets in epigenetic drug development. BRDs bind to acetylated lysine residues on histones and other proteins, significantly impacting transcriptional regulation and chromatin remodeling. As our grasp of bromodomain structures and biochemistry deepens, the momentum behind developing small-molecule inhibitors for these BRD domains is triggered and potent inhibitors targeting different family members of BRDs are proposed. In addition, computational simulations have also played a significant role in advancing inhibitor design for the BRD family. This review delves into recent breakthroughs in small-molecule BRD receptor inhibitors and computational studies, spotlighting their biological impact and therapeutic potential, and outlining the research road ahead. This review is expected to provide guidance for future drug design of BRD inhibitors.
Open AccessRecent Progress and Prospect in Studying Selective Inhibitors Toward Bromodomain Family Members
Bromodomain (BRD)-containing proteins are gaining attention as key targets in epigenetic drug development. BRDs bind to acetylated lysine residues on histones and other proteins, significantly impacting transcriptional regulation and chromatin remodeling. As our grasp of bromodomain structures and biochemistry deepens, the momentum behind developing small-molecule inhibitors for these BRD domains is triggered and potent inhibitors targeting different family members of BRDs are proposed. In addition, computational simulations have also played a significant role in advancing inhibitor design for the BRD family. This review delves into recent breakthroughs in small-molecule BRD receptor inhibitors and computational studies, spotlighting their biological impact and therapeutic potential, and outlining the research road ahead. This review is expected to provide guidance for future drug design of BRD inhibitors.
- Top Cited Papers
- 29 January 2026
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 130 (6) , 1783-1797
Allosteric Binding-Mediated Suppression on Activity of G12D KRAS Recognized via Markov State Model and Communication Pathway
The KRAS G12D mutation is one of the most common oncogenic lesions in human tumors, especially in pancreatic ductal adenocarcinoma. The monobodies 12D1 and 12D5 exhibit high selectivity for the G12D mutant of KRAS compared to the wild-type (WT) form. However, the structural and dynamic factors underlying this specificity are still not fully understood. To explore this, we analyzed the transition direction of conformations, allosteric communication pathways, and residue-residue interaction networks at the protein-protein interface. The G12D mutation causes the switch regions to transition from a closed state to an open state. Binding of 12D1 and 12D5 restores this abnormal transition. Additionally, the G12D mutation disrupts the regular communication pathway from the allosteric site α3 to the switch regions (SW I and SW II) observed in WT KRAS. Binding of 12D1 and 12D5 to the allosteric site restores this communication pathway to its original state. Detailed protein-protein interaction network analyses further reveal that 12D1 and 12D5 form two specific hydrogen bonds with the backbone carboxylate of D12. These hydrogen bonds not only strengthen the hydrophobic contacts at the monobody-KRAS interface but also correct the abnormal conformational equilibrium and restore the disrupted allosteric circuitry. Overall, our findings confirm that D12 is a structurally and functionally validated anchor for the development of next-generation inhibitors targeting G12D KRAS-driven malignancies.
- 29 January 2026
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 130 (6) , 1783-1797
Top Cited PapersAllosteric Binding-Mediated Suppression on Activity of G12D KRAS Recognized via Markov State Model and Communication Pathway
The KRAS G12D mutation is one of the most common oncogenic lesions in human tumors, especially in pancreatic ductal adenocarcinoma. The monobodies 12D1 and 12D5 exhibit high selectivity for the G12D mutant of KRAS compared to the wild-type (WT) form. However, the structural and dynamic factors underlying this specificity are still not fully understood. To explore this, we analyzed the transition direction of conformations, allosteric communication pathways, and residue-residue interaction networks at the protein-protein interface. The G12D mutation causes the switch regions to transition from a closed state to an open state. Binding of 12D1 and 12D5 restores this abnormal transition. Additionally, the G12D mutation disrupts the regular communication pathway from the allosteric site α3 to the switch regions (SW I and SW II) observed in WT KRAS. Binding of 12D1 and 12D5 to the allosteric site restores this communication pathway to its original state. Detailed protein-protein interaction network analyses further reveal that 12D1 and 12D5 form two specific hydrogen bonds with the backbone carboxylate of D12. These hydrogen bonds not only strengthen the hydrophobic contacts at the monobody-KRAS interface but also correct the abnormal conformational equilibrium and restore the disrupted allosteric circuitry. Overall, our findings confirm that D12 is a structurally and functionally validated anchor for the development of next-generation inhibitors targeting G12D KRAS-driven malignancies.
- 25 September 2025
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 129 (40) , 10256-10271
Conformational Transition and Recognition Mechanism of Eukaryotic Riboswitches Powered by Thiamine Pyrophosphate Analogues: An Elucidation through Multiple Short Molecular Dynamics Simulations and Markov Model
Understanding the ligand-mediated conformational changes in eukaryotic riboswitches is crucial for elucidating their functional roles. In this study, multiple short molecular dynamics simulations, followed by Markov model analysis, were conducted to investigate how the binding of ligands such as three thiamine pyrophosphate analogues (TPP, PYI, and D2X) influences the conformational transitions of eukaryotic riboswitches. Our findings indicate that the presence of these ligands induces a greater number of conformational states and alters the relative orientation of ligands to key nucleotides, thereby impacting ligand-riboswitch recognition. The ligands TPP, PYI, and D2X were found to exert distinct effects on the conformations of specific structural regions, including P1, P4, P5, and L3 and junctions J23 and J45. This suggests that the dynamic nature of the riboswitch of eukaryotic riboswitches is highly dependent on the conformational responses within these regions, also supported by our principal component analysis. Additionally, changes in π-π interactions of ligands with nucleotides G30 and A31, hydrogen bonds formed between ligands and nucleotide, as well as those of a magnesium ion (Mg2+) with nucleotides G48, G66, and ligands, may play a significant role in mediating the conformational transitions of eukaryotic riboswitches. Overall, this research is expected to provide valuable theoretical insights into the functions and target roles of riboswitches.
- 25 September 2025
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 129 (40) , 10256-10271
Conformational Transition and Recognition Mechanism of Eukaryotic Riboswitches Powered by Thiamine Pyrophosphate Analogues: An Elucidation through Multiple Short Molecular Dynamics Simulations and Markov Model
Understanding the ligand-mediated conformational changes in eukaryotic riboswitches is crucial for elucidating their functional roles. In this study, multiple short molecular dynamics simulations, followed by Markov model analysis, were conducted to investigate how the binding of ligands such as three thiamine pyrophosphate analogues (TPP, PYI, and D2X) influences the conformational transitions of eukaryotic riboswitches. Our findings indicate that the presence of these ligands induces a greater number of conformational states and alters the relative orientation of ligands to key nucleotides, thereby impacting ligand-riboswitch recognition. The ligands TPP, PYI, and D2X were found to exert distinct effects on the conformations of specific structural regions, including P1, P4, P5, and L3 and junctions J23 and J45. This suggests that the dynamic nature of the riboswitch of eukaryotic riboswitches is highly dependent on the conformational responses within these regions, also supported by our principal component analysis. Additionally, changes in π-π interactions of ligands with nucleotides G30 and A31, hydrogen bonds formed between ligands and nucleotide, as well as those of a magnesium ion (Mg2+) with nucleotides G48, G66, and ligands, may play a significant role in mediating the conformational transitions of eukaryotic riboswitches. Overall, this research is expected to provide valuable theoretical insights into the functions and target roles of riboswitches.
- 11 August 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Mechanics in Medicine and Biology
- Vol. 25 (08)
OPTIMIZED YOLOv9-PES ARCHITECTURE FOR ENHANCED MICROSCOPIC DETECTION OF MYCOBACTERIUM TUBERCULOSIS
Tuberculosis remains a leading cause of infectious disease mortality globally, with delayed diagnosis contributing to transmission chains and drug-resistant strains. Automating detection is thus a critical public health priority. This approach significantly reduces the likelihood of false positives or missed detections in specific scenarios. Our study focuses on high-precision detection of Mycobacterium tuberculosis in microscopic images. By optimizing the YOLO architecture, we achieved efficient recognition of microscale Mycobacterium tuberculosis targets against complex microscopic backgrounds. We adopted the latest YOLOv9 model as the foundational framework and made a series of targeted enhancements. In comparative experiments using the same dataset, our improved model achieved a mean average precision (mAP) of 89.2%, demonstrating superior accuracy compared to similar microscopic image recognition algorithms. The experimental results highlight the advantages of the YOLO model in microscopic image recognition tasks, particularly in dealing with complex backgrounds and detecting small targets. These advancements hold significant implications for both clinical workflows and global tuberculosis eradication efforts.
- 11 August 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Mechanics in Medicine and Biology
- Vol. 25 (08)
OPTIMIZED YOLOv9-PES ARCHITECTURE FOR ENHANCED MICROSCOPIC DETECTION OF MYCOBACTERIUM TUBERCULOSIS
Tuberculosis remains a leading cause of infectious disease mortality globally, with delayed diagnosis contributing to transmission chains and drug-resistant strains. Automating detection is thus a critical public health priority. This approach significantly reduces the likelihood of false positives or missed detections in specific scenarios. Our study focuses on high-precision detection of Mycobacterium tuberculosis in microscopic images. By optimizing the YOLO architecture, we achieved efficient recognition of microscale Mycobacterium tuberculosis targets against complex microscopic backgrounds. We adopted the latest YOLOv9 model as the foundational framework and made a series of targeted enhancements. In comparative experiments using the same dataset, our improved model achieved a mean average precision (mAP) of 89.2%, demonstrating superior accuracy compared to similar microscopic image recognition algorithms. The experimental results highlight the advantages of the YOLO model in microscopic image recognition tasks, particularly in dealing with complex backgrounds and detecting small targets. These advancements hold significant implications for both clinical workflows and global tuberculosis eradication efforts.
- Top Cited Papers
- 8 April 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (8) , 4189-4205
Activity Regulation and Conformation Response of Janus Kinase 3 Mediated by Phosphorylation: Exploration from Correlation Network Analysis and Markov Model
The activity of the enzyme JAK3 is modulated by tyrosine phosphorylation, yet the underlying molecular details remain not fully understood. In this study, we employed a GaMD trajectory-based Markov model and correlation network analysis (CNA) to investigate the impact of single phosphorylation (SP) at Y980 (pY980) and double phosphorylation (DP) at Y980/Y981 (pY980/pY981) on the conformational dynamics of JAK3 bound by inhibitors IZA and MI1. The Markov model analysis indicated that both SP and DP result in fewer conformational states and significantly influence the conformational dynamics of the P-loop, αC-helix, and loop1-loop3, while maintaining the hinge region's high rigidity. The CNA findings revealed that phosphorylation alters the communication network among different structural regions of JAK3, providing a rational explanation for how phosphorylation affects the conformational dynamics of the distant P-loop and loop1-loop3. Moreover, the conformational changes mediated by SP and DP further affect the interactions between the inhibitors and the hot spots (L828, V836, E903, Y904, L905, and L956) of JAK3. This work offers valuable theoretical insights into the molecular mechanisms that regulate JAK3 activity.
- 8 April 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (8) , 4189-4205
Top Cited PapersActivity Regulation and Conformation Response of Janus Kinase 3 Mediated by Phosphorylation: Exploration from Correlation Network Analysis and Markov Model
The activity of the enzyme JAK3 is modulated by tyrosine phosphorylation, yet the underlying molecular details remain not fully understood. In this study, we employed a GaMD trajectory-based Markov model and correlation network analysis (CNA) to investigate the impact of single phosphorylation (SP) at Y980 (pY980) and double phosphorylation (DP) at Y980/Y981 (pY980/pY981) on the conformational dynamics of JAK3 bound by inhibitors IZA and MI1. The Markov model analysis indicated that both SP and DP result in fewer conformational states and significantly influence the conformational dynamics of the P-loop, αC-helix, and loop1-loop3, while maintaining the hinge region's high rigidity. The CNA findings revealed that phosphorylation alters the communication network among different structural regions of JAK3, providing a rational explanation for how phosphorylation affects the conformational dynamics of the distant P-loop and loop1-loop3. Moreover, the conformational changes mediated by SP and DP further affect the interactions between the inhibitors and the hot spots (L828, V836, E903, Y904, L905, and L956) of JAK3. This work offers valuable theoretical insights into the molecular mechanisms that regulate JAK3 activity.
- Open Access
Identifying Inhibitor-SARS-CoV2-3CLpro Binding Mechanism Through Molecular Docking, GaMD Simulations, Correlation Network Analysis and MM-GBSA Calculations
The main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known as 3CLpro, is crucial in the virus’s life cycle and plays a pivotal role in COVID-19. Understanding how small molecules inhibit 3CLpro’s activity is vital for developing anti-COVID-19 therapeutics. To this end, we employed Gaussian accelerated molecular dynamics (GaMD) simulations to enhance the sampling of 3CLpro conformations and conducted correlation network analysis (CNA) to explore the interactions between different structural domains. Our findings indicate that a CNA-identified node in domain II of 3CLpro acts as a conduit, transferring conformational changes from the catalytic regions in domains I and II, triggered by the binding of inhibitors (7YY, 7XB, and Y6G), to domain III, thereby modulating 3CLpro’s activity. Normal mode analysis (NMA) and principal component analysis (PCA) revealed that inhibitor binding affects the structural flexibility and collective movements of the catalytic sites and domain III, influencing 3CLpro’s function. The binding free energies, predicted by both MM-GBSA and QM/MM-GBSA methods, showed a high correlation with experimental data, validating the reliability of our analyses. Furthermore, residues L27, H41, C44, S46, M49, N142, G143, S144, C145, H163, H164, M165, and E166, identified through residue-based free energy decomposition, present promising targets for the design of anti-COVID-19 drugs and could facilitate the development of clinically effective 3CLpro inhibitors.
Open AccessIdentifying Inhibitor-SARS-CoV2-3CLpro Binding Mechanism Through Molecular Docking, GaMD Simulations, Correlation Network Analysis and MM-GBSA Calculations
The main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known as 3CLpro, is crucial in the virus’s life cycle and plays a pivotal role in COVID-19. Understanding how small molecules inhibit 3CLpro’s activity is vital for developing anti-COVID-19 therapeutics. To this end, we employed Gaussian accelerated molecular dynamics (GaMD) simulations to enhance the sampling of 3CLpro conformations and conducted correlation network analysis (CNA) to explore the interactions between different structural domains. Our findings indicate that a CNA-identified node in domain II of 3CLpro acts as a conduit, transferring conformational changes from the catalytic regions in domains I and II, triggered by the binding of inhibitors (7YY, 7XB, and Y6G), to domain III, thereby modulating 3CLpro’s activity. Normal mode analysis (NMA) and principal component analysis (PCA) revealed that inhibitor binding affects the structural flexibility and collective movements of the catalytic sites and domain III, influencing 3CLpro’s function. The binding free energies, predicted by both MM-GBSA and QM/MM-GBSA methods, showed a high correlation with experimental data, validating the reliability of our analyses. Furthermore, residues L27, H41, C44, S46, M49, N142, G143, S144, C145, H163, H164, M165, and E166, identified through residue-based free energy decomposition, present promising targets for the design of anti-COVID-19 drugs and could facilitate the development of clinically effective 3CLpro inhibitors.
- Top Cited Papers
- 28 August 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (17) , 6880-6898
Conformations of KRAS4B Affected by Its Partner Binding and G12C Mutation: Insights from GaMD Trajectory-Image Transformation-Based Deep Learning
Binding of partners and mutations highly affects the conformational dynamics of KRAS4B, which is of significance for deeply understanding its function. Gaussian accelerated molecular dynamics (GaMD) simulations followed by deep learning (DL) and principal component analysis (PCA) were carried out to probe the effect of G12C and binding of three partners NF1, RAF1, and SOS1 on the conformation alterations of KRAS4B. DL reveals that G12C and binding of partners result in alterations in the contacts of key structure domains, such as the switch domains SW1 and SW2 together with the loops L4, L5, and P-loop. Binding of NF1, RAF1, and SOS1 constrains the structural fluctuation of SW1, SW2, L4, and L5; on the contrary, G12C leads to the instability of these four structure domains. The analyses of free energy landscapes (FELs) and PCA also show that binding of partners maintains the stability of the conformational states of KRAS4B while G12C induces greater mobility of the switch domains SW1 and SW2, which produces significant impacts on the interactions of GTP with SW1, L4, and L5. Our findings suggest that partner binding and G12C play important roles in the activity and allosteric regulation of KRAS4B, which may theoretically aid in further understanding the function of KRAS4B.
- 28 August 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (17) , 6880-6898
Top Cited PapersConformations of KRAS4B Affected by Its Partner Binding and G12C Mutation: Insights from GaMD Trajectory-Image Transformation-Based Deep Learning
Binding of partners and mutations highly affects the conformational dynamics of KRAS4B, which is of significance for deeply understanding its function. Gaussian accelerated molecular dynamics (GaMD) simulations followed by deep learning (DL) and principal component analysis (PCA) were carried out to probe the effect of G12C and binding of three partners NF1, RAF1, and SOS1 on the conformation alterations of KRAS4B. DL reveals that G12C and binding of partners result in alterations in the contacts of key structure domains, such as the switch domains SW1 and SW2 together with the loops L4, L5, and P-loop. Binding of NF1, RAF1, and SOS1 constrains the structural fluctuation of SW1, SW2, L4, and L5; on the contrary, G12C leads to the instability of these four structure domains. The analyses of free energy landscapes (FELs) and PCA also show that binding of partners maintains the stability of the conformational states of KRAS4B while G12C induces greater mobility of the switch domains SW1 and SW2, which produces significant impacts on the interactions of GTP with SW1, L4, and L5. Our findings suggest that partner binding and G12C play important roles in the activity and allosteric regulation of KRAS4B, which may theoretically aid in further understanding the function of KRAS4B.
- Open Access
Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling
Bromodomain-containing protein 9 (BRD9) is a key player in chromatin remodeling and gene expression regulation, and it is closely associated with the development of various diseases, including cancers. Recent studies have indicated that inhibition of BRD9 may have potential value in the treatment of certain cancers. Molecular dynamics (MD) simulations, Markov modeling and principal component analysis were performed to investigate the binding mechanisms of allosteric inhibitor POJ and orthosteric inhibitor 82I to BRD9 and its allosteric regulation. Our results indicate that binding of these two types of inhibitors induces significant structural changes in the protein, particularly in the formation and dissolution of α-helical regions. Markov flux analysis reveals notable changes occurring in the α-helicity near the ZA loop during the inhibitor binding process. Calculations of binding free energies reveal that the cooperation of orthosteric and allosteric inhibitors affects binding ability of inhibitors to BRD9 and modifies the active sites of orthosteric and allosteric positions. This research is expected to provide new insights into the inhibitory mechanism of 82I and POJ on BRD9 and offers a theoretical foundation for development of cancer treatment strategies targeting BRD9.
Open AccessUnveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling
Bromodomain-containing protein 9 (BRD9) is a key player in chromatin remodeling and gene expression regulation, and it is closely associated with the development of various diseases, including cancers. Recent studies have indicated that inhibition of BRD9 may have potential value in the treatment of certain cancers. Molecular dynamics (MD) simulations, Markov modeling and principal component analysis were performed to investigate the binding mechanisms of allosteric inhibitor POJ and orthosteric inhibitor 82I to BRD9 and its allosteric regulation. Our results indicate that binding of these two types of inhibitors induces significant structural changes in the protein, particularly in the formation and dissolution of α-helical regions. Markov flux analysis reveals notable changes occurring in the α-helicity near the ZA loop during the inhibitor binding process. Calculations of binding free energies reveal that the cooperation of orthosteric and allosteric inhibitors affects binding ability of inhibitors to BRD9 and modifies the active sites of orthosteric and allosteric positions. This research is expected to provide new insights into the inhibitory mechanism of 82I and POJ on BRD9 and offers a theoretical foundation for development of cancer treatment strategies targeting BRD9.
- Open Access
Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning
Inhibiting MDM2-p53 interaction is considered an efficient mode of cancer treatment. In our current study, Gaussian-accelerated molecular dynamics (GaMD), deep learning (DL), and binding free energy calculations were combined together to probe the binding mechanism of non-peptide inhibitors K23 and 0Y7 and peptide ones PDI6W and PDI to MDM2. The GaMD trajectory-based DL approach successfully identified significant functional domains, predominantly located at the helixes α2 and α2’, as well as the β-strands and loops between α2 and α2’. The post-processing analysis of the GaMD simulations indicated that inhibitor binding highly influences the structural flexibility and collective motions of MDM2. Calculations of molecular mechanics–generalized Born surface area (MM-GBSA) and solvated interaction energy (SIE) not only suggest that the ranking of the calculated binding free energies is in agreement with that of the experimental results, but also verify that van der Walls interactions are the primary forces responsible for inhibitor–MDM2 binding. Our findings also indicate that peptide inhibitors yield more interaction contacts with MDM2 compared to non-peptide inhibitors. Principal component analysis (PCA) and free energy landscape (FEL) analysis indicated that the piperidinone inhibitor 0Y7 shows the most pronounced impact on the free energy profiles of MDM2, with the piperidinone inhibitor demonstrating higher fluctuation amplitudes along primary eigenvectors. The hot spots of MDM2 revealed by residue-based free energy estimation provide target sites for drug design toward MDM2. This study is expected to provide useful theoretical aid for the development of selective inhibitors of MDM2 family members.
Open AccessInsights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning
Inhibiting MDM2-p53 interaction is considered an efficient mode of cancer treatment. In our current study, Gaussian-accelerated molecular dynamics (GaMD), deep learning (DL), and binding free energy calculations were combined together to probe the binding mechanism of non-peptide inhibitors K23 and 0Y7 and peptide ones PDI6W and PDI to MDM2. The GaMD trajectory-based DL approach successfully identified significant functional domains, predominantly located at the helixes α2 and α2’, as well as the β-strands and loops between α2 and α2’. The post-processing analysis of the GaMD simulations indicated that inhibitor binding highly influences the structural flexibility and collective motions of MDM2. Calculations of molecular mechanics–generalized Born surface area (MM-GBSA) and solvated interaction energy (SIE) not only suggest that the ranking of the calculated binding free energies is in agreement with that of the experimental results, but also verify that van der Walls interactions are the primary forces responsible for inhibitor–MDM2 binding. Our findings also indicate that peptide inhibitors yield more interaction contacts with MDM2 compared to non-peptide inhibitors. Principal component analysis (PCA) and free energy landscape (FEL) analysis indicated that the piperidinone inhibitor 0Y7 shows the most pronounced impact on the free energy profiles of MDM2, with the piperidinone inhibitor demonstrating higher fluctuation amplitudes along primary eigenvectors. The hot spots of MDM2 revealed by residue-based free energy estimation provide target sites for drug design toward MDM2. This study is expected to provide useful theoretical aid for the development of selective inhibitors of MDM2 family members.
- Open Access
Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning
CDK6 plays a key role in the regulation of the cell cycle and is considered a crucial target for cancer therapy. In this work, conformational transitions of CDK6 were identified by using Gaussian accelerated molecular dynamics (GaMD), deep learning (DL), and free energy landscapes (FELs). DL finds that the binding pocket as well as the T-loop binding to the Vcyclin protein are involved in obvious differences of conformation contacts. This result suggests that the binding pocket of inhibitors (LQQ and AP9) and the binding interface of CDK6 to the Vcyclin protein play a key role in the function of CDK6. The analyses of FELs reveal that the binding pocket and the T-loop of CDK6 have disordered states. The results from principal component analysis (PCA) indicate that the binding of the Vcyclin protein affects the fluctuation behavior of the T-loop in CDK6. Our QM/MM-GBSA calculations suggest that the binding ability of LQQ to CDK6 is stronger than AP9 with or without the binding of the Vcyclin protein. Interaction networks of inhibitors with CDK6 were analyzed and the results reveal that LQQ contributes more hydrogen binding interactions (HBIs) and hot interaction spots with CDK6. In addition, the binding pocket endures flexibility changes from opening to closing states and the Vcyclin protein plays an important role in the stabilizing conformation of the T-loop. We anticipate that this work could provide useful information for further understanding the function of CDK6 and developing new promising inhibitors targeting CDK6.
Open AccessUnveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning
CDK6 plays a key role in the regulation of the cell cycle and is considered a crucial target for cancer therapy. In this work, conformational transitions of CDK6 were identified by using Gaussian accelerated molecular dynamics (GaMD), deep learning (DL), and free energy landscapes (FELs). DL finds that the binding pocket as well as the T-loop binding to the Vcyclin protein are involved in obvious differences of conformation contacts. This result suggests that the binding pocket of inhibitors (LQQ and AP9) and the binding interface of CDK6 to the Vcyclin protein play a key role in the function of CDK6. The analyses of FELs reveal that the binding pocket and the T-loop of CDK6 have disordered states. The results from principal component analysis (PCA) indicate that the binding of the Vcyclin protein affects the fluctuation behavior of the T-loop in CDK6. Our QM/MM-GBSA calculations suggest that the binding ability of LQQ to CDK6 is stronger than AP9 with or without the binding of the Vcyclin protein. Interaction networks of inhibitors with CDK6 were analyzed and the results reveal that LQQ contributes more hydrogen binding interactions (HBIs) and hot interaction spots with CDK6. In addition, the binding pocket endures flexibility changes from opening to closing states and the Vcyclin protein plays an important role in the stabilizing conformation of the T-loop. We anticipate that this work could provide useful information for further understanding the function of CDK6 and developing new promising inhibitors targeting CDK6.